Is HBPCF or JEPQ a better dividend investment in 2026?

HBPCF currently yields 115.61% with a 5% 5-year dividend growth rate. JEPQ yields 11.10% with 5% growth. The better choice depends on your goal: HBPCF offers higher current income.

What is the dividend yield difference between HBPCF and JEPQ?

HBPCF has a forward dividend yield of 115.61% ($2.00/share annually). JEPQ yields 11.10% ($6.16/share annually). The yield gap is 104.51 percentage points.

Home › Compare › HBPCF vs JEPQ

HBPCF vs JEPQ: Dividend Comparison 2026

HBPCF yields 115.61% · JEPQ yields 11.10%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 HBPCF wins by $7.19M in total portfolio value

INVESTMENT

TIME HORIZON10 years

HBPCF

● Live price

115.61%

Share price

$1.73

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$7.23M

Annual income

$2,676,132.53

Full HBPCF calculator →

JEPQ

JPMorgan Nasdaq Equity Premium Income ETF

● Live price

11.10%

Share price

$55.52

Annual div

$6.16

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.8K

Annual income

$2,152.59

Full JEPQ calculator →

Portfolio growth — HBPCF vs JEPQ

📍 HBPCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	HBPCF	JEPQ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, HBPCF + JEPQ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

HBPCF pays

JEPQ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HBPCF

Annual income on $10K today (after 15% tax)

$9,826.59/yr

After 10yr DRIP, annual income (after tax)

$2,274,712.65/yr

JEPQ

Annual income on $10K today (after 15% tax)

$943.83/yr

After 10yr DRIP, annual income (after tax)

$1,829.70/yr

At 15% tax rate, HBPCF beats the other by $2,272,882.95/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HBPCF + JEPQ for your $10,000?

HBPCF: 50%JEPQ: 50%

100% JEPQ50/50100% HBPCF

Portfolio after 10yr

$3.64M

Annual income

$1,339,142.55/yr

Blended yield

36.82%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HBPCF buys

JEPQ buys

No recent congressional trades found for HBPCF or JEPQ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricHBPCFJEPQ

Forward yield	115.61% ✓	11.10%
Annual dividend / share	$2.00	$6.16 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$7.23M	$44.8K ✓
Annual income after 10y	$2,676,132.53 ✓	$2,152.59
Total dividends collected	$6.55M	$16.3K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: HBPCF vs JEPQ ($10,000, DRIP)

Year	HBPCF Portfolio	HBPCF Income/yr	JEPQ Portfolio	JEPQ Income/yr	Gap
1← crossover	$22,261	$11,560.69	$11,930	$1,110.39	+$10.3K → HBPCF
2	$47,870	$24,051.31	$14,133	$1,224.34	+$33.7K → HBPCF
3	$99,558	$48,337.27	$16,632	$1,340.46	+$82.9K → HBPCF
4	$200,481	$93,953.00	$19,454	$1,457.97	+$181.0K → HBPCF
5	$391,330	$176,815.76	$22,626	$1,576.08	+$368.7K → HBPCF
6	$741,281	$322,558.19	$26,175	$1,694.09	+$715.1K → HBPCF
7	$1,364,208	$571,036.96	$30,133	$1,811.32	+$1.33M → HBPCF
8	$2,441,853	$982,150.40	$34,531	$1,927.17	+$2.41M → HBPCF
9	$4,255,766	$1,642,983.32	$39,403	$2,041.08	+$4.22M → HBPCF
10	$7,229,802	$2,676,132.53	$44,787	$2,152.59	+$7.19M → HBPCF

HBPCF vs JEPQ: Complete Analysis 2026

HBPCF — Stock

Helix BioPharma Corp. operates as an immune-oncology company in Canada. The company is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. It has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with University Hospital Tuebingen to assess the therapeutic response of L-DOS47 in cancer models expressing CEACAM6, with advanced preclinical metabolic imaging. The company is headquartered in Toronto, Canada.

Full HBPCF Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →

📬

Get this HBPCF vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HBPCF vs SCHD HBPCF vs JEPI HBPCF vs O HBPCF vs KO HBPCF vs MAIN HBPCF vs XYLD HBPCF vs QYLD HBPCF vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.